← Leaderboards
Teru Hideshima
Dana-Farber Cancer Inst
$1,761,647
Attributed
$2,644,874
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $353.3K · FY2008–18$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,644,874 · 2
By mechanism
R01$1,766,455 · 1
P50$878,419 · 1
Top collaborators
- Kenneth C Anderson5 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kenneth C Anderson$25,995,373
- Benjamin Levine Ebert$26,802,844
- Donald W. Kufe$50,160,456
- Herve Avet Loiseau$3,475,894
- Constantine S. Mitsiades$5,369,219
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCell GrowthXenograft ModelIn VitroSignal TransductionInhibitor/AntagonistRefractoryTranslationsMultiple MyelomaComplexClinical TrialsBone MarrowBaseBinding (Molecular Function)Novel StrategiesOncogene ProteinsAttenuatedMucin-1 Staining MethodPathway InteractionsLinkClinical Trials DesignApoptoticMitochondriaHeat-Shock Proteins 90
Grant awards (10)
Functional and biologic significance of deacetylase3 inhibition in myeloma$353,291
R01 · FY2018 · CA · contact PI
Functional and biologic significance of deacetylase3 inhibition in myeloma$353,291
R01 · FY2017 · CA · contact PI
Functional and biologic significance of deacetylase3 inhibition in myeloma$353,291
R01 · FY2016 · CA · contact PI
Functional and biologic significance of deacetylase3 inhibition in myeloma$353,291
R01 · FY2015 · CA · contact PI
Functional and biologic significance of deacetylase3 inhibition in myeloma$353,291
R01 · FY2014 · CA · contact PI
P-3: Targeting Wnt pathway in the treatment of MM$187,645
P50 · FY2012 · CA · contact PI
P-3: Targeting Wnt pathway in the treatment of MM$179,199
P50 · FY2011 · CA · contact PI
P-3: Targeting Wnt pathway in the treatment of MM$188,093
P50 · FY2010 · CA · contact PI
P-3: Targeting Wnt pathway in the treatment of MM$187,434
P50 · FY2009 · CA · contact PI
P-3: Targeting Wnt pathway in the treatment of MM$136,048
P50 · FY2008 · CA · contact PI